Key result
Delayed defibrillation testing 2 months after CRT-D implantation was effective at first shock in 96% of patients, with a 1% acute LV lead dislodgment rate and no ICD therapy failures.
Why the study?
Is delayed defibrillation testing at 2 months safe and feasible in heart failure patients implanted with CRT-D?
Cohort (n=211)
Is delayed defibrillation testing at 2 months safe and feasible in heart failure patients implanted with CRT-D?
Delayed defibrillation testing 2 months after CRT-D implantation is safe and feasible, demonstrating a high rate of effective first shocks and low complication rates.
Answers are grounded in this paper and cite their sources.
Should not yet change practice for defibrillation testing timing after CRT-D; leaves open need for randomized confirmation of safety.
BACKGROUND: Defibrillation testing (DT) at the end of the implantation of cardiac resynchronization pacemaker with a defibrillator (CRT-D) exposes heart failure (HF) patients to increased procedural risks. However, until now, delayed DT has not been assessed as a possible option in HF patients implanted with CRT-D. OBJECTIVE: Aim of the present study is to assess safety and feasibility of delayed DT in HF patients treated with CRT-D. MATERIAL AND METHODS: Two hundred and eleven consecutive patients (mean age: 65 years, mean NYHA class 3.0, mean EF: 29.3%) underwent CRT-D implantation from October 1999 to December 2004. In the first 17 patients, DT was performed at the end of CRT-D implantation. In the other 194 consecutive patients, DT was performed at 2 months after CRT-D implantation. Outcome of DT, as well as "acute" LV lead dislodgment rate were evaluated in the latter group of 194 patients undergoing a delayed DT. Also, ICD function was assessed through device telemetry analysis at 2 months. RESULTS: At delayed DT, first shock was effective in 187 of 194 patients (96%), ineffective VF interruption at maximum energy occurred only in one patient (0.5%), and acute LV lead dislodgment was 1%. No ICD therapy failure occurred in the 2-month untested period. CONCLUSION: DT performed 2 months after CRT-D implantation is safe and feasible; this is possibly related to the improvement of clinical conditions and hemodynamic status as well as greater lead stability 2 months after CRT-D.
No takes yet. Share an insight, caveat, or question.
Gasparini et al. (2005) conducted a cohort in Heart failure patients treated with CRT-D (n=211). Delayed defibrillation testing (2 months post-implantation) vs. Immediate defibrillation testing (at end of implantation) was evaluated on First shock effectiveness at delayed defibrillation testing. Delayed defibrillation testing 2 months after CRT-D implantation was effective at first shock in 96% of patients, with a 1% acute LV lead dislodgment rate and no ICD therapy failures.
Synapse has enriched 10 related papers. Consider them for comparative context: